Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Stephen Atkin and Thozhukat Sathyapalan.
Stephen Atkin
Connection Strength
11.091
Thozhukat Sathyapalan
  1. The Effect of Atorvastatin (and Subsequent Metformin) on Adipose Tissue Acylation-Stimulatory-Protein Concentration and Inflammatory Biomarkers in Overweight/Obese Women With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2019; 10:394.
    View in: PubMed
    Score: 0.829
  2. The Effect of High Dose Isoflavone Supplementation on Serum Reverse T3 in Euthyroid Men With Type 2 Diabetes and Post-menopausal Women. Front Endocrinol (Lausanne). 2018; 9:698.
    View in: PubMed
    Score: 0.796
  3. The Effect of Phytoestrogen on Thyroid in Subclinical Hypothyroidism: Randomized, Double Blind, Crossover Study. Front Endocrinol (Lausanne). 2018; 9:531.
    View in: PubMed
    Score: 0.785
  4. Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome. Sci Rep. 2018 02 28; 8(1):3795.
    View in: PubMed
    Score: 0.757
  5. Anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2018 02; 88(2):258-262.
    View in: PubMed
    Score: 0.745
  6. The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome. Endocr Connect. 2017 Nov; 6(8):811-816.
    View in: PubMed
    Score: 0.737
  7. Salivary testosterone measurement in women with and without polycystic ovary syndrome. Sci Rep. 2017 06 15; 7(1):3589.
    View in: PubMed
    Score: 0.721
  8. Androstenedione and testosterone levels correlate with in vitro fertilization rates in insulin-resistant women. BMJ Open Diabetes Res Care. 2017; 5(1):e000387.
    View in: PubMed
    Score: 0.718
  9. Soy Protein Improves Cardiovascular Risk in Subclinical Hypothyroidism: A Randomized Double-Blinded Crossover Study. J Endocr Soc. 2017 May 01; 1(5):423-430.
    View in: PubMed
    Score: 0.711
  10. The effect of soy phytoestrogen supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2011 May; 96(5):1442-9.
    View in: PubMed
    Score: 0.465
  11. Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection? Front Endocrinol (Lausanne). 2021; 12:638621.
    View in: PubMed
    Score: 0.233
  12. Lipids and insulin regulate mitochondrial-derived peptide (MOTS-c) in PCOS and healthy subjects. Clin Endocrinol (Oxf). 2019 08; 91(2):278-287.
    View in: PubMed
    Score: 0.206
  13. The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study. Front Endocrinol (Lausanne). 2019; 10:296.
    View in: PubMed
    Score: 0.205
  14. The Effect of Soy Isoflavones on Steroid Metabolism. Front Endocrinol (Lausanne). 2019; 10:229.
    View in: PubMed
    Score: 0.204
  15. The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2019; 10:189.
    View in: PubMed
    Score: 0.204
  16. Association of Vitamin D Metabolites With Embryo Development and Fertilization in Women With and Without PCOS Undergoing Subfertility Treatment. Front Endocrinol (Lausanne). 2019; 10:13.
    View in: PubMed
    Score: 0.202
  17. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome. Nutrients. 2019 Jan 17; 11(1).
    View in: PubMed
    Score: 0.201
  18. Metabolic and proteomic signatures of hypoglycaemia in type 2 diabetes. Diabetes Obes Metab. 2019 04; 21(4):909-919.
    View in: PubMed
    Score: 0.200
  19. Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2019; 10:2042018818805674.
    View in: PubMed
    Score: 0.198
  20. Occurrence of deoxynivalenol in an elderly cohort in the UK: a biomonitoring approach. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2018 Oct; 35(10):2032-2044.
    View in: PubMed
    Score: 0.195
  21. Corrigendum: The Effect of a Simulated Commercial Flight Environment With Hypoxia and Low Humidity on Clotting, Platelet, and Endothelial Function in Participants With Type 2 Diabetes - A Cross-Over Study. Front Endocrinol (Lausanne). 2018; 9:301.
    View in: PubMed
    Score: 0.193
  22. Effects of Growth Hormone Replacement on Peripheral Muscle and Exercise Capacity in Severe Growth Hormone Deficiency. Front Endocrinol (Lausanne). 2018; 9:56.
    View in: PubMed
    Score: 0.189
  23. Assessment of Urinary Deoxynivalenol Biomarkers in UK Children and Adolescents. Toxins (Basel). 2018 01 23; 10(2).
    View in: PubMed
    Score: 0.188
  24. Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss. BMC Endocr Disord. 2017 Jul 14; 17(1):41.
    View in: PubMed
    Score: 0.181
  25. Deoxynivalenol Biomarkers in the Urine of UK Vegetarians. Toxins (Basel). 2017 06 22; 9(7).
    View in: PubMed
    Score: 0.180
  26. Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity. Front Endocrinol (Lausanne). 2021; 12:658304.
    View in: PubMed
    Score: 0.060
  27. Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection? Front Endocrinol (Lausanne). 2021; 12:665134.
    View in: PubMed
    Score: 0.060
  28. Platelet Protein-Related Abnormalities in Response to Acute Hypoglycemia in Type 2 Diabetes. Front Endocrinol (Lausanne). 2021; 12:651009.
    View in: PubMed
    Score: 0.059
  29. Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19. Sci Rep. 2021 03 19; 11(1):6428.
    View in: PubMed
    Score: 0.058
  30. Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome. J Transl Med. 2021 Mar 15; 19(1):106.
    View in: PubMed
    Score: 0.058
  31. Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome. J Transl Med. 2021 02 11; 19(1):63.
    View in: PubMed
    Score: 0.058
  32. The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome. Metabol Open. 2021 Mar; 9:100079.
    View in: PubMed
    Score: 0.058
  33. COVID-19 biomarkers for severity mapped to polycystic ovary syndrome. J Transl Med. 2020 12 22; 18(1):490.
    View in: PubMed
    Score: 0.057
  34. Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis. Metabol Open. 2021 Mar; 9:100074.
    View in: PubMed
    Score: 0.057
  35. Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: Biomarker response to hypoglycemia. Metabolism. 2021 01; 114:154417.
    View in: PubMed
    Score: 0.057
  36. Renin-Angiotensin System overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection? Metabol Open. 2020 Sep; 7:100052.
    View in: PubMed
    Score: 0.056
  37. Renin-Angiotensin System Overactivation in Type 2 Diabetes: A Risk for SARS-CoV-2 Infection? Diabetes Care. 2020 10; 43(10):e131-e133.
    View in: PubMed
    Score: 0.056
  38. The CD105:CD106 microparticle ratio is CD106 dominant in polycystic ovary syndrome compared to type 2 diabetes and healthy subjects. Endocrine. 2019 11; 66(2):220-225.
    View in: PubMed
    Score: 0.052
  39. Bariatric Surgery Modulates Urinary Levels of MicroRNAs Involved in the Regulation of Renal Function. Front Endocrinol (Lausanne). 2019; 10:319.
    View in: PubMed
    Score: 0.051
  40. Improved physiology and metabolic flux after Roux-en-Y gastric bypass is associated with temporal changes in the circulating microRNAome: a longitudinal study in humans. BMC Obes. 2018; 5:20.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.